Brokers Offer Predictions for VRCA Q4 Earnings
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) – Brookline Capital Management issued their Q4 2025 earnings estimates for shares of Verrica Pharmaceuticals in a research note issued on Tuesday, March 11th. Brookline Capital Management analyst K. Dolliver anticipates that the company will earn ($0.03) per share for the quarter. The consensus estimate for Verrica Pharmaceuticals’ […]
